Clinical trial
Stepped-Wedge Randomized Control Trial to Compare Integrated, Co-located, Telemedicine-based HCV Management for Individuals on Opiate Agonist Treatment Versus Usual Care Treatment of HCV of Individuals on Opiate Agonist Treatment
NCT02933970 is registered in ClinicalTrials.gov with Andrew Talal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stepped-Wedge Randomized Control Trial to Compare Integrated, Co-located, Telemedicine-based HCV Management for Individuals on Opiate Agonist Treatment Versus Usual Care Treatment of HCV of Individuals on Opiate Agonist Treatment
- Lead sponsor
- Andrew Talal
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2017
- Completion date
- November 1, 2022
- Enrollment
- 602 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.